Literature DB >> 34708725

Co-existing retinal pathologies: Diagnostic challenges in diabetic retinopathy.

Aniruddha Agarwal1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34708725      PMCID： PMC8725074          DOI： 10.4103/ijo.IJO_2504_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN： 0301-4738            Impact factor:   1.848


× No keyword cloud information.
  6 in total

1.  Histopathologic study of presumed parafoveal telangiectasis.

Authors:  B Eliassi-Rad; W R Green
Journal:  Retina       Date:  1999       Impact factor: 4.256

2.  Type 2 idiopathic macular telangiectasia.

Authors:  Dhananjay Shukla; Shashank R Gupta; Nithya Neelakantan; Sachin Tiwari; Sumi Gupta; Aditi R Patwardhan; Thayyil B Soubhya
Journal:  Retina       Date:  2012-02       Impact factor: 4.256

3.  Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2.

Authors:  Raja Narayanan; Jay Chhablani; Manish Sinha; Vivek Dave; Mudit Tyagi; Rajeev R Pappuru; Baruch D Kuppermann
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

4.  Idiopathic macular telangiectasia.

Authors:  Lawrence A Yannuzzi; Anne M C Bardal; K Bailey Freund; Kuan-Jen Chen; Chiara M Eandi; Barbara Blodi
Journal:  Arch Ophthalmol       Date:  2006-04

5.  Optical coherence tomography angiography findings of fellow eye of proliferative macular telangiectasia type 2: Long term study.

Authors:  Sumit Randhir Singh; Samantha Fraser-Bell; Avantika Dogra; Niroj Kumar Sahoo; Pierre-Henry Gabrielle; Marco Lupidi; Mayss Al-Sheikh; Enrico Borrelli; Riccardo Sacconi; Giuseppe Querques; Jay Chhablani
Journal:  Eur J Ophthalmol       Date:  2020-07-02       Impact factor: 2.597

6.  Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy.

Authors:  Mahima Jhingan; Kerul Marsonia; Dhananjay Shukla; Philip J Rosenfeld; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2017-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.